Global Age Related Macular Degeneration Drug Sales Market Report Forecast 2017-2021

May 2017 | 115 pages | ID: G89B661FEF8EN
S&P Consulting

Abstracts

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

Key market segments and sub-segments
Evolving market trends and dynamics
Changing supply and demand scenarios
Quantifying market opportunities through market sizing and market forecasting
Tracking current trends/opportunities/challenges
Competitive insights
Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:

United States
China
Europe
Japan

The Major players reported in the market include:

Roche/Genentech
Novartis
Regeneron
Bayer
Valeant
Allergan
Alimera Sciences
Ophthotech
Acucela

Product Segment Analysis:

Type 1
Type 2
Type 3

Application Segment Analysis:

Application 1
Application 2
Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

Global Age Related Macular Degeneration Drug Sales Market Report Forecast 2017-2021

1 AGE RELATED MACULAR DEGENERATION DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Age Related Macular Degeneration Drug
1.2 Classification of Age Related Macular Degeneration Drug
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Age Related Macular Degeneration Drug
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Age Related Macular Degeneration Drug Market States Status and Prospect (2012-2021) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Age Related Macular Degeneration Drug (2012-2021)
  1.5.1 Global Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2021)
  1.5.2 Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)

2 GLOBAL ECONOMIC IMPACT ON AGE RELATED MACULAR DEGENERATION DRUG INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURING COST ANALYSIS

3.1 Age Related Macular Degeneration Drug Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Age Related Macular Degeneration Drug

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Age Related Macular Degeneration Drug Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
4.4 Downstream Buyers

5 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Age Related Macular Degeneration Drug Market Competition by Manufacturers
  5.1.1 Global Age Related Macular Degeneration Drug Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Age Related Macular Degeneration Drug Revenue and Share by Manufacturers (2012-2017)
5.2 Global Age Related Macular Degeneration Drug (Volume and Value) by Type
  5.5.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
  5.5.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
5.3 Global Age Related Macular Degeneration Drug (Volume and Value) by Regions
  5.3.1 Global Age Related Macular Degeneration Drug Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2012-2017)
5.4 Global Age Related Macular Degeneration Drug (Volume) by Application

6 UNITED STATES AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 United States Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  6.1.1 United States Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  6.1.2 United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  6.1.3 United States Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
6.2 United States Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
6.3 United States Age Related Macular Degeneration Drug Sales and Market Share by Type
6.4 United States Age Related Macular Degeneration Drug Sales and Market Share by Application

7 CHINA AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 China Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  7.1.1 China Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  7.1.2 China Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  7.1.3 China Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
7.2 China Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
7.3 China Age Related Macular Degeneration Drug Sales and Market Share by Type
7.4 China Age Related Macular Degeneration Drug Sales and Market Share by Application

8 EUROPE AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  8.1.1 Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  8.1.2 Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
8.2 Europe Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
8.3 Europe Age Related Macular Degeneration Drug Sales and Market Share by Type
8.4 Europe Age Related Macular Degeneration Drug Sales and Market Share by Application

9 JAPAN AGE RELATED MACULAR DEGENERATION DRUG (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Age Related Macular Degeneration Drug Sales and Value (2012-2017)
  9.1.1 Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
  9.1.2 Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
9.2 Japan Age Related Macular Degeneration Drug Sales and Market Share by Manufacturers
9.3 Japan Age Related Macular Degeneration Drug Sales and Market Share by Type
9.4 Japan Age Related Macular Degeneration Drug Sales and Market Share by Application

10 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MANUFACTURERS ANALYSIS

10.1 Roche/Genentech
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Novartis
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Regeneron
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 Bayer
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Valeant
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Allergan
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Alimera Sciences
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 Ophthotech
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Acucela
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL AGE RELATED MACULAR DEGENERATION DRUG MARKET FORECAST (2017-2021)

13.1 Global Age Related Macular Degeneration Drug Sales, Revenue Forecast (2017-2021)
13.2 Global Age Related Macular Degeneration Drug Sales Forecast by Regions (2017-2021)
13.3 Global Age Related Macular Degeneration Drug Sales Forecast by Type (2017-2021)
13.4 Global Age Related Macular Degeneration Drug Sales Forecast by Application (2017-2021)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Age Related Macular Degeneration Drug
Table Classification of Age Related Macular Degeneration Drug
Figure Global Sales Market Share of Age Related Macular Degeneration Drug by Type in 2015
Table Applications of Age Related Macular Degeneration Drug
Figure Global Sales Market Share of Age Related Macular Degeneration Drug by Application in 2015
Figure United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure China Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Figure Global Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2021)
Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2021)
Table Global Age Related Macular Degeneration Drug Sales of Key Manufacturers (2012-2017)
Table Global Age Related Macular Degeneration Drug Sales Share by Manufacturers (2012-2017)
Figure 2015 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Figure 2016 Age Related Macular Degeneration Drug Sales Share by Manufacturers
Table Global Age Related Macular Degeneration Drug Revenue by Manufacturers (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table 2016 Global Age Related Macular Degeneration Drug Revenue Share by Manufacturers
Table Global Age Related Macular Degeneration Drug Sales and Market Share by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Sales Share by Type (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue and Market Share by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Type (2012-2017)
Figure Global Age Related Macular Degeneration Drug Revenue Growth Rate by Type (2012-2017)
Table Global Age Related Macular Degeneration Drug Sales and Market Share by Regions (2012-2017)
Table Global Age Related Macular Degeneration Drug Sales Share by Regions (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Regions (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue and Market Share by Regions (2012-2017)
Table Global Age Related Macular Degeneration Drug Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Age Related Macular Degeneration Drug by Regions (2012-2017)
Figure Global Age Related Macular Degeneration Drug Revenue Growth Rate by Regions (2012-2017)
Table Global Age Related Macular Degeneration Drug Sales and Market Share by Application (2012-2017)
Table Global Age Related Macular Degeneration Drug Sales Share by Application (2012-2017)
Figure Sales Market Share of Age Related Macular Degeneration Drug by Application (2012-2017)
Figure Global Age Related Macular Degeneration Drug Sales Growth Rate by Application (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure United States Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure United States Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales by Manufacturers (2012-2017)
Table United States Age Related Macular Degeneration Drug Market Share by Manufacturers (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales by Type (2012-2017)
Table United States Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Table United States Age Related Macular Degeneration Drug Sales by Application (2012-2017)
Table United States Age Related Macular Degeneration Drug Market Share by Application (2012-2017)
Figure China Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure China Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure China Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table China Age Related Macular Degeneration Drug Sales by Manufacturers (2012-2017)
Table China Age Related Macular Degeneration Drug Market Share by Manufacturers (2012-2017)
Table China Age Related Macular Degeneration Drug Sales by Type (2012-2017)
Table China Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Table China Age Related Macular Degeneration Drug Sales by Application (2012-2017)
Table China Age Related Macular Degeneration Drug Market Share by Application (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Europe Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales by Manufacturers (2012-2017)
Table Europe Age Related Macular Degeneration Drug Market Share by Manufacturers (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Table Europe Age Related Macular Degeneration Drug Sales by Application (2012-2017)
Table Europe Age Related Macular Degeneration Drug Market Share by Application (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Sales and Growth Rate (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Revenue and Growth Rate (2012-2017)
Figure Japan Age Related Macular Degeneration Drug Sales Price Trend (2012-2017)
Table Japan Age Related Macular Degeneration Drug Sales by Manufacturers (2012-2017)
Table Japan Age Related Macular Degeneration Drug Market Share by Manufacturers (2012-2017)
Table Japan Age Related Macular Degeneration Drug Sales by Type (2012-2017)
Table Japan Age Related Macular Degeneration Drug Market Share by Type (2012-2017)
Table Japan Age Related Macular Degeneration Drug Sales by Application (2012-2017)
Table Japan Age Related Macular Degeneration Drug Market Share by Application (2012-2017)
Table Roche/Genentech Basic Information List
Table Roche/Genentech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Roche/Genentech Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Novartis Basic Information List
Table Novartis Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Regeneron Basic Information List
Table Regeneron Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Regeneron Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Bayer Basic Information List
Table Bayer Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Bayer Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Valeant Basic Information List
Table Valeant Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Valeant Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Allergan Basic Information List
Table Allergan Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Allergan Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Alimera Sciences Basic Information List
Table Alimera Sciences Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Alimera Sciences Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Ophthotech Basic Information List
Table Ophthotech Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Ophthotech Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Acucela Basic Information List
Table Acucela Age Related Macular Degeneration Drug Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Acucela Age Related Macular Degeneration Drug Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Age Related Macular Degeneration Drug
Figure Manufacturing Process Analysis of Age Related Macular Degeneration Drug
Figure Age Related Macular Degeneration Drug Industrial Chain Analysis
Table Raw Materials Sources of Age Related Macular Degeneration Drug Major Manufacturers in 2015
Table Major Buyers of Age Related Macular Degeneration Drug
Table Distributors/Traders List
Figure Global Age Related Macular Degeneration Drug Sales and Growth Rate Forecast (2017-2021)
Figure Global Age Related Macular Degeneration Drug Revenue and Growth Rate Forecast (2017-2021)
Table Global Age Related Macular Degeneration Drug Sales Forecast by Regions (2017-2021)
Table Global Age Related Macular Degeneration Drug Sales Forecast by Type (2017-2021)
Table Global Age Related Macular Degeneration Drug Sales Forecast by Application (2017-2021)

COMPANIES MENTIONED

Roche/Genentech, Novartis, Regeneron, Bayer, Valeant, Allergan, Alimera Sciences, Ophthotech, Acucela, Ohr Pharmaceuticals